Mary Francisco, MD
Pediatric Gastroenterology · Kingsport, TNNPI 1801899521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 37.6% of the total. Reporting peaked in 2021 at $877 and has fallen 77.4% since, to $198 in 2025.
Across 113 payments — averaging $23.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$984
- QOL Medical, LLC$296
- Ironwood Pharmaceuticals, Inc$213
- Takeda Pharmaceuticals U.S.A., Inc.$157
- Gilead$131
- Supernus Pharmaceuticals, Inc.$99
- plus $736 from 21 others
What the payments were for
- Food & beverage$2,618100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $984 |
| QOL Medical, LLC | 14 | $296 |
| Ironwood Pharmaceuticals, Inc | 2 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $157 |
| Gilead | 5 | $131 |
| Supernus Pharmaceuticals, Inc. | 4 | $99 |
| Johnson & Johnson(2 entities) | 5 | $87 |
| GSK | 4 | $66 |
| Nestle Healthcare Nutrition Inc. | 4 | $62 |
| Boston Scientific | 4 | $61 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Amgen(2 entities) | 3 | $47 |
| UCB, Inc. | 2 | $41 |
| Pfizer | 2 | $39 |
| Shire North American Group Inc | 2 | $37 |
| Corium, LLC | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $27 |
| TG Therapeutics, Inc. | 1 | $25 |
| Biogen | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Argenx US, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
| Octapharma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$106
How this compares
$2,618 in reported general payments places this provider in the 75th percentile of 42 pediatric gastroenterology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric gastroenterology in Kingsport
- Dennis BlackMemphis$87K
- John EshunMemphis$26K
- Girish HiremathNashville$21K
- Youhanna Al-TawilKnoxville$9K
- David DevoidKnoxville$6K
- Conrad CoxBrentwood$4K
- Anjali MalkaniJohnson City$3K
- Ligia Alfaro CruzJohnson City$3K
- Chad ThornhillKnoxville$3K
- Douglas LamanChattanooga$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.